Abstract
The subcutaneous implantable cardioverter defibrillator (ICD) provides therapy for the prevention of sudden cardiac death while avoiding the numerous complications associated with transvenous leads. This relatively novel device employs an innovative approach to sensing and defibrillation from outside of the thoracic cage. Substantial data from cohort studies and registries have accrued and can be used to inform patient eligibility, implant technique, and efficacy compared with the standard transvenous ICD. This review serves to update the clinician as to current evidence and the nuances involved in the optimal utilization of this innovative technology.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 247-257 |
| Number of pages | 11 |
| Journal | European Heart Journal |
| Volume | 38 |
| Issue number | 4 |
| DOIs | |
| State | Published - 2017 |
Keywords
- ICD implant
- Subcutaneous implantable cardioverter defibrillator
- Sudden cardiac death
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Fingerprint Dive into the research topics of 'The subcutaneous implantable cardioverter defibrillator: State-of-the-art review'. Together they form a unique fingerprint.
Cite this
McLeod, C. J., Boersma, L., Okamura, H., & Friedman, P. A. (2017). The subcutaneous implantable cardioverter defibrillator: State-of-the-art review. European Heart Journal, 38(4), 247-257. https://doi.org/10.1093/eurheartj/ehv507